On-going studies

Acronyme Sponsor/Promoteur Titre du projet Lien vers CT
ADRENOSS II  ADRENOMED Treatment of Patients With Early Septic Shock and Bio-Adrenomedullin(ADM) Concentration > 70 pg/ml With ADRECIZUMAB  NCT03085758
ART123  ASAHI KASEI PHARMA Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy NCT01598831
CALO2-001  COMBIOXIN SA Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae NCT02583373
CAPE-COD  CHU Tours Community-Acquired Pneumonia : Evaluation of Corticosteroids NCT02517489
COMBACTE - EVADE IMI - MedImmune Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects  NCT02696902
COMBACTE - SAATELLITE IMI - MedImmune Study of the Efficacy and Safety of MEDI4893  NCT02296320
MOT-C-201  INOTREM Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM in Patients With Septic Shock NCT03158948
SEPCELL  TIGENIX Cx611-0204 SEPCELL Study  NCT03158727
SPRINT SARI  Australian and New Zealand Intensive Care Research Centre Short PeRiod IncideNce sTudy of Severe Acute Respiratory Infection NCT02498587
THANE  Assistance Publique - Hôpitaux de Paris Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock  NCT02120404
TRIAGE  BIOMERIEUX TRIAGE: TRIage of Sepsis At emerGency dEpartment NCT02739152








CRICS-TRIGGERSEP « Clinical Research in Intensive Care and Sepsis - TRIal Group for Global Evaluation and Research in SEPsis »